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Abstract
Background: To investigate how the risk of active tuberculosis disease is influenced by time since original
infection and to determine whether the risk of reactivation of tuberculosis increases or decreases with age.
Methods: Cohort analysis of data for the separate ten year birth cohorts of 1876-1885 to 1959-1968 obtained from
Statistics Norway and the National Tuberculosis Registry. These data were used to calculate the rates and the
changes in the rates of bacillary (or active) tuberculosis. Data on bacillary tuberculosis for adult (20+) age groups
were obtained from the National Tuberculosis Registry and Statistics Norway from 1946 to 1974. Most cases during
this period arose due to reactivation of remote infection. Participants in this part of the analysis were all reported
active tuberculosis cases in Norway from 1946 to 1974 as recorded in the National Tuberculosis Registry.
Results: Tuberculosis decreased at a relatively steady rate when following individual birth cohorts, but with a
tendency of slower decline as time passed since infection. A mean estimate of this rate of decline was 57% in a 10
year period.
Conclusions: The risk of reactivation of latent tuberculosis decreases with age. This decline may reflect the rate at
which latent tuberculosis is eliminated from a population with minimal transmission of tubercle bacilli. A model for
risk of developing active tuberculosis as a function of time since infection shows that the rate at which
tuberculosis can be eliminated from a society can be quite substantial if new infections are effectively prevented.
The findings clearly indicate that preventative measures against transmission of tuberculosis will be the most
effective. These results also suggest that the total population harbouring live tubercle bacilli and consequently the
future projection for increased incidence of tuberculosis in the world is probably overestimated.
Background
Depending on the epidemiological situation and the
local infectious pressure, the probability of development
of clinical disease after infection with Mycobacterium
tuberculosis varies. It is often stated that among those
infected, about 10% progress to active disease over their
liftetime [1]. The risk of disease development is highest
within the first year, estimated then to be 1%, and con-
siderably lower the second year (0.3%) after which the
risk is further gradually reduced [2]. The risk of late-
appearing clinical disease is mainly due to the ability of
M. tuberculosis to enter into a dormant stage followed
by reactivation. After infection, latency can be defined
as a state with no signs or symptoms of active tubercu-
losis. Skin test reactivity determined by intracutaneous
injection of purified protein derivative (PPD) of
M. tuberculosis and/or x-ray demonstration of a healed,
calcified lesion have generally been used as evidence of
previous infection or primary tuberculosis disease [3],
while interferon-gamma release assays represent an
important technical development for diagnosis of latent
tuberculosis [4]. Observations on latent tuberculosis
with M. tuberculosis residing in healthy individuals were
made already by Opie and Aronson who cultured
M. tuberculosis from apparently normal tissues of indivi-
duals who died from other causes, and who had no
pathological evidence of tuberculosis disease [5]. During
latency the bacilli show a characteristic location outside
of the primary complex, i.e. in the upper lobes corre-
sponding to the main location of cavernae in reactiva-
tion tuberculosis [6]. These findings have been extended
with molecular methods [7]. Polymerase chain reaction
for the IS6110 sequence revealed M. tuberculosis DNA
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in paraffin sections of macroscopically normal upper
lobe lung tissue from 15 of 47 Ethiopian and Mexican
individuals dying from causes other than tuberculosis.
There are also observations indicating that the same
bacterial strain induced active disease more than
20 years after original infection. From Denmark particu-
larly interesting observations were made by comparing
clinical isolates from the 1960s with isolates from the
1990s [8,9]. Two M. tuberculosis strains isolated from a
father in 1961 and his son in 1994 had identical IS6110
restriction fragment length polymorphism (RFLP) pat-
tern. The father had smear positive pulmonary tubercu-
losis with a one year case history in 1961, successfully
treated for 12 months with streptomycin, isoniazid and
para-aminosalicylic acid. His son was then 7 years old,
left the home in 1972 without further contact with his
father, and presented with pulmonary tuberculosis in
1994. This identical RFLP pattern of the two isolates
was not found in any other strain, either among 130 his-
torical strains collected 1961-1967 or among 4008
recent strains collected 1992-1999 [8].
An important question is for how long the latent stage
of tuberculosis is continuing with a risk of reactivation
and development of clinical disease. It is widely assumed
that latency is life-long and that most new cases of
active tuberculosis in low-endemic countries arise from
a growing proportion of latently infected individuals
[10], and that infected individuals thus face an increas-
ing risk of reactivation as they grow older [11]. It is,
however, possible that infected individuals gradually
tend to clear the latent infection. If this is the case one
may predict that the rate of reactivated tuberculosis
decreases as a function of time since primary infection.
When tuberculosis came under control in Norway
after the Second World War, the annual incidence of
new infections diminished rapidly, and the majority of
clinical cases now occurred after reactivation of remote
infection [12,13]. Data from molecular epidemiological
characterization of isolated M. tuberculosis strains in
low incidence countries show that there is very little
recent transmission of tuberculosis in the native popula-
tion under these conditions [14-16]. Molecular finger-
printing data from Norway shows a very diverse strain
repertoire with very little clustering of cases among
native Norwegians. This is as expected when reactiva-
tion occurs sporadically.
The National Tuberculosis Registry and Statistics Nor-
way provide data for new cases of bacillary tuberculosis
in 10 year cohorts from the age of 20. Data are given as
incidence, i.e. cases per 100,000 population per year,
making it possible to follow the rate of tuberculosis in
birth cohorts from young adulthood until old age.
Analysis of tuberculosis in sequential birth cohorts was
originally introduced by Kristian Andvord studying
tuberculosis mortality at the end of the 19th and begin-
ning of the 20th century [17-19]. Our analysis aimed to
determine whether these data from the Norwegian
experience after the Second World War can be used to
estimate the duration of the latent stage and the asso-
ciated risk of reactivation and development of clinical
disease.
Methods
Setting
Data on all registered cases in Norway of bacillary
tuberculosis for age specific groups in the years of 1946-
1974 and for the separate ten year birth cohorts of
1876-1885 to 1959-1968 were obtained from the
National Tuberculosis Registry and from Statistics Nor-
way (Statistisk sentralbyrå) at http://www.ssb.no/aarbok/.
Diagnosis of tuberculosis
The term “bacillary tuberculosis” was used for notifica-
tion and registration of tuberculosis disease, i.e. cases
being sputum smear positive, and/or culture positive for
M. tuberculosis, and/or having cavernous tuberculosis by
X-ray examination, and/or “phitisis progrediens”. This
definition was consistently used in Norway throughout
the study period. The data in these registries are quite
unique in accessing information of a total population
over a very long period of time from a material that is
well recognized for its high quality. A common national
requirement for reporting of tuberculosis disease was
important to ensure completeness of these data.
Tuberculin testing
Extensive data on tuberculin skin testing are also acces-
sible in the National Tuberculosis Registry. The decline
of tuberculosis was analysed during the years of 1946-
1974, i.e. prior to immigration affecting the tuberculosis
epidemiology in Norway to avoid immigration as con-
founding factor in the analysis.
Strobe analysis
STROBE analysis was performed according to the
checklist of items that should be included in reports of
observational studies.
Statistical analysis
The statistical analysis was performed using SPSS
version 15.0 (SPSS Inc., Chicago, Illinois; U.S.A). The
significance level for all statistical tests was P < 0.05.
The lowest probability recorded by the program is
P < 0.0005.
Results
The data in Table 1 show how the epidemiology of
tuberculosis differed in successive birth cohorts as per
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January 1st 1973. The data are taken from figure 2
(males) and figure 3 (females) in Haider and Tverdal’s
publication [20]. There was a substantial decrease in
percentages of spontaneous tuberculin positive indivi-
duals as well as individuals with positive X-ray findings.
BCG vaccination coverage increased substantially and
reached 92% in the youngest birth cohort.
The striking change in reporting of tuberculosis dis-
ease in Norway is illustrated in Figure 1A and 1B. In
1948 the highest rates of notified cases of active tuber-
culosis recorded as “bacillary tuberculosis” were seen
among the young adults. In 1968 the situation had
changed completely and reported case rates showed a
steady increase with age. The situation as seen in 1968
is typical of a low prevalence setting and is sometimes
misinterpreted to indicate that an infected person’s
chance of developing tuberculosis from latent infection
increases in old age.
The national statistics of reported tuberculosis cases in
Norway provide data which enabled us to study the
tuberculosis case rates in separate 10 year birth cohorts.
Table 2 shows the mean annual rates of tuberculosis per
100,000 inhabitants for men and women, respectively, as
notified for separate ten year birth cohorts of 1879-1888
up to 1959-1968 in the years 1948, 1958, 1968, 1978
and 1988. The graphic picture of the cohorts is shown
in Figure 2A and 2B for men and women respectively.
Interestingly, there is a substantial decrease in notified
tuberculosis cases for all birth cohorts as they grow
older and the decline appears to have followed a similar
rate in all cohorts as can be seen from the largely paral-
lel curves. This indicates that the rate of decline in the
cohorts is similar in this population.
In order to investigate this more closely, all available
data for birth cohorts from 1876 to 1954 in the period
1946 to 1974 were used to calculate the reduction in
disease rates over 10 year periods. This was found to be
57% on average, 55% for men and 59% for women. The
rate of decline was found to be highest for the youngest
individuals, i.e. age group 20-40 years old and less
marked, but still substantial for the oldest age groups
(Figure 3). A similar rate of decline was found when
analysing the data in relation to year of observation
(data not shown). This indicates that the rate of decline
is influenced by the time passed since original infection.
Taken together these data were used to draw a model
for risk of developing active tuberculosis as a function
of time since original infection (Figure 4A). Assuming
that the rate of decline of reactivated tuberculosis
reflects the clearance of latent tuberculosis, a model was
drawn to indicate how fast Mycobacterium tuberculosis
can be eliminated from a population (Figure 4B).
Table 1 Background information about the cohorts per January 1st 1973.
Men Spontaneous tuberculin
negative1
BCG
vaccinated2
Spontaneous tuberculin
positive3
Positive X-ray findings and/or previous
tuberculosis disease4
Birth cohort
1949-1958 35 92 3 2
1939-1948 2 86 8 4
1929-1938 4 61 25 10
1919-1928 9 30 44 17
1909-1918 13 10 52 25
1899-1908 16 1 51 32
Women
Birth cohort
1949-1958 3 92 2 3
1939-1948 4 84 8 4
1929-1938 8 62 20 10
1919-1928 13 38 35 14
1909-1918 22 13 45 20
1899-1908 27 2 44 27
The data presented in this table were taken from Haider and Tverdal [20], and were included to show the status for the cohorts with respect to tuberculin
reactivity, BCG vaccination and X-ray findings towards the end of the study period.
1Percentage of tuberculin positive persons that later turned tuberculin negative.
2Percentage of BCG vaccinated persons.
3Percentage of tuberculin negative persons that later turned tuberculin positive without the influence of BCG vaccination.
4Percentage of persons with evidence for previous tuberculosis.
5Values represent percentage of the total population of the birth cohort.
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Figure 1 Notified rates of bacillary tuberculosis in the various age groups of men (A) and women (B) in 1948 and 1968 respectively.
The data were obtained from the National Tuberculosis Registry and Statistics Norway.
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Discussion
Can reduction in transmission and newly infected cases
explain the sharp decrease in the overall incidence of
tuberculosis after 1945? This may have contributed
partly in the beginning of the observation period but
later there was very little transmission of tubercle bacilli.
The percentages of tuberculin reactors in the cohorts
with case rates above 100/100,000, i. e. prior to 1930,
were quite high. Data on selected populations are avail-
able from Norway showing that among 30 year old indi-
viduals about 70% were tuberculin positive in 1927-28.
This fell to 45% in 1944 and 10% in 1951-52 [21]. The
birth cohorts prior to the Second World War had a sub-
stantial proportion of latently infected individuals, but
removal of this fraction by death explains only a small
part of the sharp decrease in notified cases. In the birth
cohort of 1949-1958 only about 3-5 per cent became
infected with M. tuberculosis. New infections had been
reduced quite substantially and continued to fall in the
1960s to negligible levels. Annual conversion rates based
on tuberculin testing of unvaccinated school children
gives a good measure of how the level of transmission
of tuberculosis in the society changed. In 1929 this was
6.4% among 2nd to 6th grade children [13]. This fell to
0.57% in 1950-51 and to 0.089% in 1968-69 [12]. This
represents an annual decline of approximately 10% per
year. The decline in transmission of tubercle bacilli was
faster than the decline of bacillary cases of tuberculosis
in the period, and would tend to give an overestimation
of the rate of clearance of latent tuberculosis. However,
considering that the majority of tuberculosis cases were
due to reactivation of latent infection, the influence of
recent infection for the estimation of rate of clearance
of latency would be small in the 1950s and almost abol-
ished in the 1960s and 1970s. An estimate showed that
reduction in recent transmission accounts for less than
10% of the decline in total tuberculosis rates during the
1950s. Because most of the tuberculosis cases were due
to remote infection the decline of tuberculosis would
then reflect how latent tuberculosis became increasingly
less able to establish active disease as time passed.
Any condition which can compromise host immune
response would interfere with a “normal” course of wan-
ing of latent infection as studied here. This can be HIV
infection or impact of war/displacement/imprisonment/
malnutrition of people etc. Therefore one needs to be
careful in extrapolation of these findings to other popu-
lations. Some confounding factors will have a negative
influence and some factors will have a positive influence
on the estimation of the decline of tuberculosis in the
period. The fact that the effect is very similar in the dif-
ferent age groups strongly supports that the reduced
incidence of tuberculosis among persons who had once
been infected was due to a decreasing number of indivi-
duals harbouring live tubercle bacilli. Importantly,
chemo-prophylaxis was not used in Norway, so the
elimination of latent tuberculosis can not be ascribed to
the use of chemotherapy.
BCG vaccination may have influenced the findings.
However, BCG will mainly prevent primary tuberculosis
and furthermore, BCG was given to tuberculin negative
individuals only which implies that the tuberculosis
infected part of the population did not receive BCG.
Consequently BCG vaccination did not influence the
rate of reactivation in previously infected individuals.
The levels of vaccine coverage varied in the cohorts and
was highest in the later cohorts (Table 1). Even so, the
rate of decline of tuberculosis was highly similar
between the cohorts. In conclusion, BCG vaccination
had little impact on the rate of decline during the study
period. This does not mean that BCG vaccination did
not influence the decline of tuberculosis in Norway,
only that a possible effect on reactivation was marginal
at best.
Table 2 Notifed cases of bacillary tuberculosis in Norway
in separate birth cohorts.
Age group
Men 20-29 30-39 40-49 50-59 60-69 70-79
Birth cohort
1959-1968 6
1949-1958 2.5 3
1939-1948 8.5 5 3
1929-1938 462 17 11 6
1919-1928 2861 752 25 18 11
1909-1918 1781 762 32 30 17
1899-1908 1611 772 58 34
1889-1898 1341 822 42
1879-1888 732
Women Age group
Birth cohort 20-29 30-39 40-49 50-59 60-69 70-79
1959-1968 1.5
1949-1958 2 2
1939-1948 5.5 3 2
1929-1938 35.52 12 3 4
1919-1928 2441 462 18 6 5
1909-1918 1281 342 13 9 6
1899-1908 801 302 19 9
1889-1898 571 322 18
1879-1888 252
The data were obtained from the National Tuberculosis Registry and Statistics
Norway, and are sorted according to sex and age per 100,000 population in
10 year cohorts. Values represent annual rates of tuberculosis per 100,000
population. By combining the data from the birth cohort and age group it
appears that the data are derived from the years 19481, 19582, and similarly
from 1968, 1978 and 1988.
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Figure 2 Notified bacillary tuberculosis among 10 year cohorts of men (A) and women (B) according to age of cohort. The data cover
birth cohorts from 1889-1898 up to 1939-1948. The individual curves are labelled with the birth years of the cohorts. The data were obtained
from the National Tuberculosis Registry and Statistics Norway.
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Figure 3 Percentage decline over 10 year periods of bacillary tuberculosis related to mean age of 10 year cohorts of men (A) and
women (B) in the period 1946 to 1974. The observations of tuberculosis disease in 10 year cohorts were collected from 1946, 1956 and 1966;
and then from another set of cohorts in 1947, 1957 and 1967 etc. The percentage change within each 10 year period was recorded as
percentage decline for each cohort from 1946 to 1956 and from 1956 to 1966 etc. The figure derived from the observation of the cohort of
20-29 years in 1946 being 30-39 years in 1956 is represented as a single point in the figure under the mean age of 30 in the observation period.
The figures of this age group was derived using independent observation of tuberculosis disease in the years of 1946-56, 1947-57, 1948-58 etc
Each point therefore represents the observed decline within each 10 year period for every birth cohort as calculated from the rates given by the
National Tuberculosis Registry and Statistics Norway. Linear curve estimation was made using the regression module of SPSS version 15.0 with
the mean age of 10 year cohorts in 10 year periods as the independent variable. The curve estimations were significant with P < 0,0005 and the
estimated declines were -0,882 for men (A) and -1,044 for women (B).
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Figure 4 (A) A model describing the risk of developing active tuberculosis in Norway as a function of time (in years) after infection.
The model is based on data from Ferebee [2] up to ten years after infection. The curve was extended beyond 10 years based on the expected
decline in the risk of development of tuberculosis as determined by the cohort analysis of this study. (B) This model shows the rate of
clearance of latent tuberculosis from a population where all persons have been infected, and assuming that transmission of
tuberculosis was completely stopped at time 0. The cohort analysis showed an average rate of 57% decline of tuberculosis over a 10 year
period, and this was used as the basis for this model. Clearance by natural death was not considered.
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Comstock [22] also reported decline of tuberculosis
within birth cohorts. From his data it can be seen that
the annual decrease in reported tuberculosis case rates
among US adults was consistently about 5% in the birth
cohorts of 1903, 1913, 1923, and 1933 when they were
followed from 1953 to 1972. Similar data were obtained
on the declining incidence of tuberculosis in Arkansas,
USA [23], where authors used molecular fingerprinting
data to estimate the relative contributions of recent and
remotely acquired infection to the yearly incidence of
tuberculosis. They showed that the incidence of non-
clustered cases declined more dramatically than the inci-
dence of clustered cases. This suggests that the decline
in rates resulted primarily from declining rates of dis-
ease due to reactivation of past infections.
From the data given in Table 1[20], it should also be
noted that a relatively high percentage of persons who
had been tuberculin positive, later turned tuberculin
negative. This is recorded as “spontaneous tuberculin
negative” in the table and was more substantial among
women than among men, an observation which is in con-
cordance with the faster decline of bacillary tuberculosis
in women (Figure 3). This conversion of a substantial
proportion of tuberculin positives to tuberculin negative
status is evidence for waning of the tuberculin reaction.
Similar observations have been made during a long-time
study on the epidemiology of tuberculosis in Ontario,
Canada [24]. The tuberculin test measures delayed type
hypersensitivity and depends on the presence of memory
T-cells. Waning of specific delayed type hypersensitivity
may indicate that mycobacterial antigen is degraded and
disappear from the body. It is recently suggested that the
Quantiferon responses also wane [25]. The expected
infection prevalence estimated by the authors from a ser-
ies of studies was 3 to 5 times higher than Quantiferon
positivity rates. Longitudinal studies are however needed
to confirm these observations.
In a cohort study from Hong Kong, England and
Wales a similar decline of tuberculosis in cohorts late
after infection was observed in England and Wales, but
not in Hong Kong [26]. The authors of this paper did
not reach a decisive conclusion. Our interpretation is
that there was a change in the general risk of contract-
ing tuberculosis in the Hong Kong society which
appeared after 1982. This is particularly apparent in the
curves for male cohorts where a change to higher tuber-
culosis rates kicked in simultaneously for all cohorts
older than 30 years. This change is coincident with an
increasing integration with the Chinese society upon the
treaty between the United Kingdom and the People’s
Republic of China signed in 1984, and is probably due
to immigration of populations from settings with a
higher prevalence of tuberculosis combined with higher
rates of transmission of tuberculosis in the Hong Kong
society.
In conclusion, our study shows that the rate at which
tuberculosis can be eliminated from a society is substan-
tial if new infections are effectively prevented. Another
conclusion is that the total population harbouring live
tubercle bacilli in the world is probably overestimated,
and needs to be recalculated based on rates of clearance
of the latent infection. In societies with a high infection
pressure such as in South Africa [27-29], high tubercu-
losis rates will be maintained because there will be sub-
stantial levels of exogenous re-infection contributing to
maintaining latency. In societies where ongoing trans-
mission has been reduced to a low level, the half-life of
latent tuberculosis would be about 8.8 years, i.e. after
8.8 years the number of individuals with latent tubercu-
losis would be reduced with 50%.
Conclusions
The current findings and analysis underscore that
tuberculosis control should be targeted at transmission
of infection. It is necessary to invest more to trace and
treat patients with smear positive tuberculosis
with minimal diagnostic delay. This is essential to coun-
teract the recent spread of hypervirulent strains of
M. tuberculosis [30] with an increased tendency to
develop multi-drug-resistant- and extensively drug-resis-
tant tuberculosis [31].
There is a considerable focus on research on latent
tuberculosis. Molecular microbiologists are intrigued
by the ability of M. tuberculosis to survive for years in
the host and the mechanisms for reactivation are of
considerable immunological interest. However, in
health systems research in the global perspective it is
essential to prioritise work which directly targets
reduction of transmission. This will include measures
to secure early diagnosis and efficient treatment of
active disease as well as research into new vaccines
that aim at improving protective immunity against pri-
mary tuberculosis being more efficient than conven-
tional BCG vaccination. In several populations latent
tuberculosis appears to be more rapidly cleared than
previously thought.
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